Evidence map›Paper›PMID 40146669›Full record

ArticlePloS one2025

Empirical calibration of a simulation model of opioid use disorder.

R W M A Madushani, Jianing Wang, Michelle Weitz, Benjamin P Linas, Laura F White, Stavroula A Chrysanthopoulou

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

R W M A MadushaniSection of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, United States of America.
Jianing WangDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.ORCID 0000-0003-4709-3091
Michelle WeitzSection of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, United States of America.
Benjamin P LinasSection of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, United States of America.
Laura F WhiteDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
Stavroula A ChrysanthopoulouDepartment of Biostatistics, Brown University School of Public Health, Providence, Rhode Island, United States of America.ORCID 0000-0001-5580-4397

Funding

Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI ZACHARY Franklin MEISEL · 2015 to 2026
$20.7M
Researching Effective Strategies to Prevent Opioid Death (RESPOND)R01DA046527 · NIDA · BOSTON MEDICAL CENTER · PI Benjamin P. Linas · 2018 to 2026
$7.2M
Maximizing Investigators' Research Award (R35)R35GM141821 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WHITE, LAURA FORSBERG · 2021 to 2025
$1.8M
NIDA NIH HHS P30 DA040500NIDA NIH HHS R01 DA046527NIGMS NIH HHS R35 GM141821
6 · The paper itself

Abstract

backgroundSimulation models of opioid use disorder (OUD) aim at evaluating the impact of different treatment strategies on population-level outcomes. Researching Effective Strategies to Prevent Opioid Death (RESPOND) is a dynamic population, state-transition model that simulates the Massachusetts OUD population synthesizing data from multiple sources. Structural complexity and scarcity of available data for opioid modeling pose a special challenge to model calibration. We propose an empirical calibration approach applicable to complex simulation models in general.

methodsWe implement an empirical approach to calibrate RESPOND to multiple targets: annual fatal opioid-related overdoses, detox admissions, and OUD population sizes. The empirical calibration involves Latin hypercube sampling for searching a multidimensional parameter space comprising arrivals, overdose rates, treatment transition rates, and substance use state transition probabilities. The algorithm accepts proposed parameters when the respective model outputs lie within pre-determined target uncertainty ranges. This is an iterative process resulting in a set of parameter values for which the model closely fits all the calibration targets. We validated the model assessing its accuracy to projections important for shared decision-making of OUD outside the training data.

resultsThe empirical calibration resulted in a model that fits well both calibration and validation targets. The flexibility of the algorithm allowed us to explore structural and parameter uncertainty, reveal underlying relationships between model parameters and identify areas of model improvement for a more accurate representation of the OUD dynamics. DISCUSSION: The proposed empirical calibration approach is an efficient tool for approximating parameter distributions of complex models, especially under complete uncertainty. Empirically calibrated parameters can be used as a starting point for a more comprehensive calibration exercise, e.g., to inform priors of a Bayesian calibration. The calibrated RESPOND model can be used to improve shared decision-making for OUD.

Indexed as

Opioid-Related DisordersAlgorithmsCalibrationComputer SimulationHumansMassachusetts

Identifiers

PMID40146669
PMCPMC11949371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.